Study: Fish Oils Plus Statins Help Protect Heart

Study: Fish Oils Plus Statins Help Protect Heart
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days. Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day. Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day. Study Shows Standardized White Bean Extract Reduces the GI of White Bread Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%. Study Shows Standardized White Bean Extract Reduces the GI of White Bread Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. Eating More Than Five Portions Of Fruit And Vegetables a Day Can Substantially Reduce The Risk Of Stroke UK researchers reveiwed data from eight studies involving over 257 500 people from Europe, Japan, and the USA, observing that compared to individuals who have less than three fruit and vegetable servings a day, those with three to five servings per day had an 11% reduction in the incidence of stroke, while those with more than five servings per day had a relative reduction of 26%. Eating More Than Five Portions Of Fruit And Vegetables a Day Can Substantially Reduce The Risk Of Stroke UK researchers reveiwed data from eight studies involving over 257 500 people from Europe, Japan, and the USA, observing that compared to individuals who have less than three fruit and vegetable servings a day, those with three to five servings per day had an 11% reduction in the incidence of stroke, while those with more than five servings per day had a relative reduction of 26%. Tonalin® CLA Study Among 'Most Noteworthy' in ODS Annual Bibliography Tonalin® CLA (conjugated linoleic acid) research documenting the long-term safety and efficacy of Tonalin® CLA supplementation, published in the American Journal of Clinical Nutrition (Gaullier J-M. et al., Am. J. Clin. Nutr., 2004; 79(6):1118-1125), was selected as one of 25 “exemplary” papers to appear in the National Institutes of Health (NIH) Office of Dietary Supplements’ (ODS) Annual Bibliography of Significant Advances in Dietary Supplement Research 2004. Tonalin® CLA Study Among 'Most Noteworthy' in ODS Annual Bibliography Tonalin® CLA (conjugated linoleic acid) research documenting the long-term safety and efficacy of Tonalin® CLA supplementation, published in the American Journal of Clinical Nutrition (Gaullier J-M. et al., Am. J. Clin. Nutr., 2004; 79(6):1118-1125), was selected as one of 25 “exemplary” papers to appear in the National Institutes of Health (NIH) Office of Dietary Supplements’ (ODS) Annual Bibliography of Significant Advances in Dietary Supplement Research 2004. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Fish Oil Supplements Prevent Declines in Heart Rate Variability Fish Oil Supplements Prevent Declines in Heart Rate Variability Fish Oil Supplements Prevent Declines in Heart Rate Variability Fish Oil Supplements Prevent Declines in Heart Rate Variability Fish Oil Supplements Prevent Declines in Heart Rate Variability Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. New Study On Saw Palmetto Demonstrates Puzzling Results A new study on saw palmetto’s role in relieving symptoms of benign prostatic hyperplasia, published in the February 9 issue of the New England Journal of Medicine, showed inconsistent conclusions to those found in the existing body of scientific literature on the popular dietary supplement. New Study On Saw Palmetto Demonstrates Puzzling Results A new study on saw palmetto’s role in relieving symptoms of benign prostatic hyperplasia, published in the February 9 issue of the New England Journal of Medicine, showed inconsistent conclusions to those found in the existing body of scientific literature on the popular dietary supplement. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. Study: Popular Herbal Therapy No Better Than Placebo New England Journal of Medicine double-blind, placebo controlled study examines saw palmetto for Benign Prostatic Hyperplasia (BPH) and finds that after one year, there was no difference in symptom changes between the group taking saw palmetto and those recieiving placebo, contradicting previous research. What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges. What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Files Suit Against KGK Synergize SourceOne Files Suit Against KGK Synergize SourceOne Files Suit Against KGK Synergize Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit.	According to a Reuters article citing a Japanese study of 18,645 patients, presented at the American Heart Association's annual scientific meeting, eicosapentaenoic acid (EPA) -- a form of omega-3 fatty acid, when taken with statin drugs, offered a further reduction of 19% in a variety of adverse heart events, reducing the number from 3.5% with statin alone, to 2.8% incidence of negative heart outcomes. According to the article, the follow up period was 4.5 years and the EPA dose was 1,800 milligrams.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software